$FRPT

Cyr William B. sold $3.0M of FRPT

Cyr William B. (Chief Executive Officer) sold 41,022 shares of Freshpet, Inc. (FRPT) at $72.86 ($2.99M total) on 2026-08-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Cyr William B.
Published Aug 19, 2026, 8:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 19, 2026, 8:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FRPT
Bearish
medium confidence
Mentioned
$FRPT
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FRPTBearishLow
01

Why it matters

The transaction reduces insider ownership and may influence investor sentiment.

02

Market read

Freshpet insider sale is a material corporate event that could affect short‑term price dynamics.

03

What to watch

CEO may be diversifying holdings or funding personal obligations; the 10b5‑1 plan pre‑arranged.

Relevance 5/10Novelty 6/10Timing: filing disclosed on Aug 19, 2026

Background

Form 4 filing provides the first public disclosure of the CEO's share sale.

Company-level read

Ticker impact

$FRPTBearishMedium confidence
Context

CEO Cyr William B. sold 41,022 shares for $2.99M via a 10b5‑1 plan on Aug 17, reducing his stake to 267,152 shares.

Expected impact

Potential modest dip in the near‑term as the market digests the $3M sale.

Evidence & confidence

Insider sales of this size from the CEO are material for a mid‑cap pet food company and often trigger short‑term bearish sentiment.

Market effects

Pet food sector may see slight caution as investors monitor insider activity.

U.S. market participants may adjust short‑term positions in FRPT.

Limited to Freshpet; no broader market effect.

Counterpoint

The sale could be a routine liquidity event unrelated to fundamentals.

Key entities

  • Freshpet, Inc.

    Pet food manufacturer listed on NASDAQ.

  • Cyr William B.

    Chief Executive Officer of Freshpet.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FRPTHighAI 9/10

Freshpet (FRPT) Q2 2026 Earnings Call Transcript

Freshpet (FRPT) reported Q2 2026 results ahead of its guidance range, with its strongest growth rate in over a year and highest adjusted gross margin since Q1 2020. The company raised 2026 sales and adjusted EBITDA guidance. It cited 41% digital order growth to 16.7% of sales, and expects 700 rural lifestyle retail stores by year-end.

$FRPTMed

Freshpet (FRPT) Is Up 12.4% After Raising 2026 Sales Outlook And Margins Improving - Has The Bull Case Changed?

Freshpet (FRPT) shares rose 12.4% after the company reported Q2 sales of $305.59 million and net income of $19.49 million, with improved year-to-date profitability and EPS. Freshpet said a shift toward loyal “MVP” households and higher adjusted gross margin supported lifting 2026 sales growth guidance to 10% to 12%, and it completed an $86.5 million share repurchase.

$FRPTHighAI 9/10

Freshpet CEO says company delivered its strongest growth rate in more than a year, as company announces 2nd quarter results

Freshpet reported Q2 2026 net sales up 15.5% to $305.6 million and gross profit of $128.7 million, 42.1% of sales. Net income rose to $19.5 million. CEO Billy Cyr cited stronger growth and highest adjusted gross margin since Q1 2020. The company updated 2026 guidance to 10% to 12% net sales growth and $210 million to $220 million adjusted EBITDA.

$FRPTHighAI 9/10

Why Are Freshpet (FRPT) Shares Soaring Today

Freshpet (FRPT) shares rose 12.7% after the company reported strong Q2 2026 results. Net sales were $305.6 million, up 15.5% year over year and above the $292.3 million consensus. EPS was $0.39 versus $0.22 expected. Adjusted EBITDA and a full-year adjusted EBITDA forecast midpoint of $215 million also beat estimates.

$FRPTMed

Freshpet Q2 Earnings Call Highlights

Freshpet (FRPT) said its low-end sales outlook assumes stable macro conditions, while hitting the high end would require stronger advertising, omnichannel gains, more distribution, faster category growth, and a return of trade-up. Q2 adjusted gross margin rose 170 bps to 48.6%. 2026 adjusted gross margin improvement guidance increased to 100 to 150 bps at the midpoint. Operating cash flow rose 31% to $44.4M; free cash flow was $14.7M.

$FRPTMedAI 8/10

Freshpet’s (NASDAQ:FRPT) Q2 CY2026: Strong Sales, Stock Soars

Freshpet (NASDAQ:FRPT) reported Q2 CY2026 results. Revenue rose 15.5% year on year to $305.6 million, exceeding Wall Street estimates by 4.5%, and GAAP profit was $0.39 per share, 73.6% above consensus. The article also cites analyst expectations for 7.1% revenue growth over the next 12 months and notes the stock rose 7.6% to $67.10 after the report.